KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Operating Leases: 2019-2024

Historic Operating Leases for Quest Diagnostics (DGX) over the last 6 years, with Dec 2024 value amounting to $535.0 million.

  • Quest Diagnostics' Operating Leases fell 1.66% to $534.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $534.0 million, marking a year-over-year decrease of 1.66%. This contributed to the annual value of $535.0 million for FY2024, which is 19.31% down from last year.
  • Latest data reveals that Quest Diagnostics reported Operating Leases of $535.0 million as of FY2024, which was down 19.31% from $663.0 million recorded in FY2023.
  • Quest Diagnostics' Operating Leases' 5-year high stood at $679.0 million during FY2021, with a 5-year trough of $535.0 million in FY2024.
  • Over the past 3 years, Quest Diagnostics' median Operating Leases value was $651.0 million (recorded in 2022), while the average stood at $616.3 million.
  • Its Operating Leases has fluctuated over the past 5 years, first increased by 12.86% in 2020, then declined by 19.31% in 2024.
  • Over the past 5 years, Quest Diagnostics' Operating Leases (Yearly) stood at $667.0 million in 2020, then increased by 1.80% to $679.0 million in 2021, then dropped by 4.12% to $651.0 million in 2022, then rose by 1.84% to $663.0 million in 2023, then dropped by 19.31% to $535.0 million in 2024.